Amlodipine potentiates metalloproteinase activity and accelerates elastin degradation in a model of aneurysmal disease  by Boyle, J.R. et al.
Eur l Vasc Endovasc Surg 16, 408-414 (1998) 
Amlodipine Potentiates Metalloproteinase Activity and Accelerates 
Elastin Degradation in a Model of Aneurysmal Disease 
J. R. Boyle, I. M. Loftus, S. Goodall, M. Crowther, P. R. F. Bell and M. M. Thompson* 
Department of Surgery, Lezcester University, U.K. 
Aims: abdominal aortw aneurysms are characterlsed by changes zn the extracellular matrzx of the arterzal medza, m 
pa~tzcular a reduction zn elastm concentratwn. These changes are me&ated by increased levels of endogenous matrix 
metalloprotemases (MMPs) Recently, calczum channel blockers have been shown to increase the proteolytzc actlvity of 
MMP-2 secreted by vascular smooth muscle cells It may therefore by hypotheszsed that calcium antagomsts may potentiate 
the actlwty of MMPs in aneurysmal dzsease and thus accelerate AAA expanszon. In thzs study, the abzhty of amlo&pme 
- a calczum antagomst - to influence lastin degradatzon, was assessed in a prewously described model of aneurysmal 
dzsease. 
Methods: porcine aortzc segments (n = 8) were pre-mcubated zn exogenous pancreatzc elastase for 24 h przor to culture 
m standard conditions for 6 days wzth 10 and IO0#gfl amlodzpzne. Control segments were cultured both wzth and 
wzthout amlo&pme and without elastase. At the terminatwn of culture MMPs were extracted from the tzssue and 
quantzfied by a combinatzon of substrate gel enzymography and mununoblottmg The volume fractions of elastm and 
collagen were determined by stereologzcaI nalysis of EVG stained sectwns. 
Results: gel enzymography demonstrated slgntficantly increased MMP-9 activity m the amlodtpme treated segments, 
me&an 4 218 vs. 2.809 arbitrary unzts (p<O.01) and this elevated actzv#y was reflected zn a slgn~cant destructzon of 
medzal elastm 27.0 vs. 40.5% (p<O.05) 
Conclusion: therapeutzc ranges of amlodipme szgmficantly enhanced elastm degradatzon and potentzated MMP-9 activity 
wzthm the aortic organ cultures. 
Introduction between individuals, however, remains poorly un- 
derstood, despite the establishment of a greater under- 
The incidence of abdominal aortic aneurysms i in- standing of the underlying pathophysiology of 
creasing, with aged standardised death rates rising 20- aneurysmal disease. 
fold in men and 11-fold in women in England and Aneurysmal disease is characterised by a pro- 
Wales between 1950 and 1984.1 The ageing population gressive depletion of elastin from the arterial wall. This 
and improved iagnosis may account for part of this occurs on a background oflocally enhanced proteolytlc 
increase; however, a clear rxse in the prevalence of activity; with in particular increased levels of tissue 
AAA at autopsy in Sweden has been demonstrated. 2 matrix metalloproteinases (MMPs) reported in aortic 
The rise in incidence is in contrast to that of peripheral aneurysms. 8 The MMPs are a family of zinc dependent 
vascular disease, despite similar risk factor profiles. 3 enzymes that have the capability to degrade all com- 
The reasons for this apparent disparity remain un- ponents of the extracellular matrix. Mesenchymal cells, 
determined, of the arterial wall, and infiltrating white blood cells 
The growth rate of aortic aneurysms i said to be secrete these nzymes. The enzymes are divided on the 
exponential, with small AAAs expanding by 10% of basis of their substrate specificity into the collagenases 
their diameter per year, 4'5 and significantly faster in (MMP-1), the gelatinases (MMP-2 and -9) and the 
patients who are hypertensive or those who smoke. 6 stromelysms (MMP-3). 9 Recent evidence has suggested 
Collin identified a sub-population of patients with that elevated levels of MMPs may be the crucial de- 
small AAAs, detected by screening, who demonstrated terminant of aneurysm formation and growth as all 
members of the elastolytic and collagenolytic MMPs rapid growth to 5.5 cm 7 The variation of growth rates 
are demonstrable in aneurysm tissue at elevated 
levels.8,10-16 
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ability of doxycycline (a non-specific MMP inhibitor) and cultured for a further 6 days in standard culture 
to inhibit MMP activity and elastin degradahon i  medium or culture medium supplemented by two 
animal studies. 17'18 In addition to MMP antagonists, concentrations of amlodipine (10 gg/1 and 100 gg/1). 
certain substances may potentiate MMP activity. A The experiment was replicated in eight separate aortas. 
recent study has demonstrated that calcium ant- One aortic segment was harvested fresh, another was 
agonists pecifically increased the proteolytic activity cultured in standard conditions for 7 days, without 
of MMP-2 of vascular smooth muscle cells (VSMCs) prior exposure to elastase, and four segments were 
and pulmonary fibroblasts in cell culture and inhibited exposed to porcine elastase for 24 h. One of these four 
the transcription of tissue inhibitor of metal- segments was harvested after 24 h and the remaining 
loprotelnase-2 (TIMP-2). I9 With these findings in mind three were cultured for 6 days in standard medium 
it may be hypothesised that calcium antagonists may and medium supplemented by amlodipine (Pfizer, 
potentiate the activity of MMPs in aneurysmal disease Sandwich, U.K.) at a concentration of 10 ~g/1 and 
with the further potential to accelerate aneurysm 100 gg/1. At the termination oforgan culture the tissue 
growth. We set out to test this hypothesis nvestigating was divided into two equal segments which were 
the effects of amlodipine (a dLhydropyridine calcium prepared for histological evaluation and metal- 
antagonist) in an organ culture model of aneurysmal loproteinase quantification. 
disease. 2°The model utilised porcine aortic segments, 
which were cultured in sterile conditions. The seg- 
ments were exposed to a brief pulse of exogenous 
elastase, to initiate matrix degradation and endo- Histology 
genous MMP production. The arterial organ culture 
model facilitated the study of isolated cellular inter- Following fixation in formalin, samples were de- 
actions and allowed the investigation ofvarious doses hydrated in 99% industrial methylated spirit (Sigma, 
of amlodipine within the system. Poole, U.K.), transferred into xylene (Sigma, Poole, 
U.K.) for 4 h, and embedded in paraffin wax. Sections 
(4 gm) were stained with both haematoxylin a d eosin 
(H&E) and Miller's elastin and van Gieson's stain 
Methods (EVG).~ 
Organ culture 
Porcine thoracic aortas were kindly provided by Daw- Stereological tissue analysis 
kms International Ltd (Nuneaton, U.K.). Aortas were 
retrieved fresh and transported in minimal essential The volume fractions of elastin, collagen and smooth 
medium on ice. Under sterile conditions, fat and loose muscle cells in the extracellular matrix were de- 
adventitial tissues were removed. One cm 2 segments termined by stereotogical nalysis as described pre- 
of aorta were excised and pruned, intimal surface viously. 23'24 Aortic sections, stained with EVG, were 
uppermost, onto a polyester gauze support resting on viewed at 400 x magnification using an Olympus 
slygard resin (Dow Cornmg, Seneffe, Belgium), in the microscope incorporating an eyepiece graticule with 
base of a 6-cm Petri dish (Fisons Loughborough, U.K.). a 100-point test grid (Graticules Ltd, Kent, U.K.). One 
Samples were denuded of endothelium and cultured hundred test points were then analysed with test 
for 7 days in standard medium (7 ml) containing 5% points hitting black indicating elastin, points hitting 
foetal calf serum (Sera Lab, Crawley, U.K.), which was yellow indicating smooth muscle cells, and points 
changed after 24 h and then every 48 h. 2°'21 hitting pink indicating collagen. Following analysm, 
the relative volume fraction of each component was 
calculated. To maintain a constant frame of reference 
throughout all experiments, the adventitial aspect of 
Experimental design the media was point counted, with eight randomly 
chosen fields quantified for each sample. Stereological 
Porcine aortic segments were pre-incubated in culture tissue analysis reflects the ability of the tissue to take 
medium supplemented with porcine pancreatic elas- up histological stain, and thus measures of collagen, 
tase (100 units/ml) (Calbiochem, Nottingham, U.K.) elastin and smooth muscle cells, reflect changes in the 
for 24 h. After this period aortic samples were washed relative concentrations of each of these lements, rather 
thoroughly to remove all traces of exogenous elastase than changes in protein content. 
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Previous experiments have determined the inter- Statistical nalysis 
observer limits of agreement for this technique m our 
institution, a° Median values and interquartile ranges for the volume 
fractions of elastin, collagen and smooth muscle cells 
were calculated for all sections. These were then com- 
pared using non-paired, non-parametric analysis 
Gel enzymography (Mann-Whitney U-test). 
Metalloproteinases were extracted from frozen tissue The densitometric analyses of MMPs were also 
using the method of Vine and Powell 1° as previously compared using the non-parametric Wilcoxon rank 
test. described, a°Tissue was thawed over ice, diced into 
i mm 3 pieces and homogenised in buffer. The homo- 
genate was centrifuged, dialysed and the protein con- 
centration was standardised for each sample to 0.9 mg/  Results 
ml with phosphate-buffered saline. 
Substrate gels were prepared by incorporating el- Stereologzcal analysis 
atm (1 mg/ml - Sigma, Poole, U.K.) into a 10% SDS- 
polyacrilamide gel. Fifteen microlitres of standardised The histological appearances of four paired aortic 
tissue extract plus an equal volume of non-reducing segments are illustrated in Fig. 1. There was no re- 
sample buffer were loaded onto the gel. Electro- duction in the elastin concentration i  the sections 
phoresis was performed at 60 mA for 4 h at 4 °C with of aorta cultured in standard conditions for 7 days. 
the Mini-Protean II sytem (Bio-Rad, Hemel Hempsted, Exposure to a 24 h pulse of elastase (9100 u/ml) in- 
U.K.), after which the gel was washed three times with duced matrix degradation i a time dependent manner 
2.5% Triton X-100 (Sigma, Poole, U.K.), incubated in as described previously, 2°resulting m significant el- 
buffer for 18h and finally stained with Coomassie astin depletion at 7 days. 
Blue R250. The molecular weight of each band was Stereological analysis confirmed that there was a 
estimated by comparison with the positions of known significant acceleration of elastin degradation m the 
molecular weight standards (Bio-Rad, Hemel Hemp- elastase xposed aortic sections cultured in standard 
stead, U.K.). The relative density of each lytic band medium supplemented by amlodipme (100 pg/1), 
was determined from negative photographic images when compared to the sections not treated with am- 
of gels with a Pharmacia LKB Imagemaster scanning lodipine (p<0.05, W= 87.5, 95% CI 0.00, 24.00). There 
densitometer (Pharmacxa LKB, St Albans, Herts, U.K.) was also a trend to elastin destruction in the sections 
and expressed as a product of the optical density and treated with a dose of 10 ~tg/1, although this was not 
area of the band. The protein concentration utilised in significant (p = 0.345, W = 77.5, 95% CI -4.99, 16.5). 
this analysis had been previously determined to be The percentage elastm concentration for all aortic seg- 
within thelinearrangefordensitometricquantification merits is xllustrated in Fig. 2. The median con- 
(data not shown). To allow for variation between centrations of elastin and the interquartile ranges are 
zymographic gels, all paired samples were run on the tabulated in Table 1. 
same gel, and paired statistics used in analysis. No 
comparison was made between different gels. 
Gelatinolytic activzty 
Immunoblotting Gelatin enzymography conhrmed a time dependent 
increase in MMP activity within elastase treated cul- 
Tissue extracts were fractionated on a 10% SDS-poly- tures compared to the control samples. Fresh aortic 
acrylamide and transferred to a nitrocellulose mem- tissue demonstrated lytic bands at 70 kDa, whilst elas- 
brane (Hybond ECL, Amersham, U.K.) in the Mira- tase treated samples demonstrated a progressive in- 
transblott apparatus (Bio-Rad, Hemel Hempsted, U.K.) crease in gelatinolytic activity at 70 kDa (doublet), and 
as previously described 20 Mouse monoclonal anti- appearance ofproteolytic bands at 90 kDa and 250 kDa. 
bodies specific for MMP-2, MMP-9, TIMP-1 and TIMP- Immunoblotting with specific monoclonal anti- 
2 (Oncogene Science, Paris, France) were used to bodies demonstrated immunoreactivity of a 70 kDa 
identify MMPs and TIMPs within the samples. These doublet with MMP-2 antibody and a 90 and 250 kDa 
anti-human antibodies had been demonstrated to cross protein reactin with an antibody to MMP-9 (data not 
react with porcine proteins in a prior study) ° shown). 
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Fig. 1. Four hmtologmal sechons from the same aorta stained with Miller's elastm and van Gmson's tare ( x 400) The cultured control 
(la), and three sechons exposed to a pulse of elastase, one subsequently cultured m standard medmm (lb), one m standard medmm 
supplemented by amIo&pme 10 gg/1 (lc0 and one m standard medmm supplemented by amlo&pme 100 gg/l (ld) 
Table 1. Median concentrations of elastin and interquartile ranges. 
60 
Aorta % Elastm + mterquartlle range 
~ 50 Cultured control 54 25 (45 375-62 25) 
Elastase 40 5 (27 25-48 75) 
Elastase/amlo&pine 10 ~tg/1 33 62 (27 94-40 75) 
= Elastase/amlodlpme 100 ~tg/1 27 00 (18 5-38 25) 40 
30 cultured in standard medium after elastase xposure 
(p =0.007, W=42.0, CI -2.082, -0.419, and p =0.013, 
20 W=44.0, CI -2.153, -0.231, for amlodipine con- 
centrations of 10gg/1 and 100gg/1, respectively). 
MMP-9 activity in arbitrary densltometnc umts is 
10 illustrated in Fig. 4. The enhanced MMP-9 activity was 
C E A10 A100 
*(p < o 05) accompanied by lesser increases in both proMMP-2 
(p=0.128, W=53.0 and p =0.318, W=58 0) and active 
Fig. 2. Graph plotting percentage lastm concentrahon (me&an MMP-2 (p=0.227, W=56.0 and p=0.083, W=51.0) 
values and Q3) for cultured control (C), elastase xposed after 7 activity, although this was  not  significant for am-  
days (E), amlodlpme treated 10 gg/1 (A10) and amlodlpme treated 
100,g/l(A100) lodipine concentrations of 10 and 100gg/1 re- 
spectively). 
A representative zymogram of four paired aortic Immunoblottmg for the endogenous MMP in- 
sections is depicted in Fig. 3. Densitometric analysis hibitors, the tissue inhibitors of metalloproteinases 
of the aortic segments treated with amlodipine dem- (TIMP-1 and TIMP-2) demonstrated a reduction in 
onstrated that these samples had significantly en- TIMP-2 activity in the amlodipine treated segments 
hanced MMP-9 achvlty, when compared to those (data not shown). 
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Cultured Elastase Amlodipme Amlo&pme 
control 10 pg/ml 100 gg/ml 
-- MMP 9 
-- Pro MMP 2 
- -  MMP 2 
Fig. 3. Gelatin zymogram showmg metalloprotemase achvlty for all sechons of one aorta and demonstrating enhanced MMP-2 and 
MMP-9 actwity m the amlodlpme treated segments. 
I ** ] hydrocortisone precipitated demonstrated that aortic 
5 rupture in genetically susceptible mice and caused 
aneurysm formation in normal mice. 26 Similarly, B- 
aminoproprionitrile (BAPN) fed broad breasted white 
turkeys uccumb from aortic dissection, BAPN causing 
a marked disruption of elastin and collagen fibres. 27 
4 A greater understanding of the pathophysiology of 
; aneurysmal disease has been recently established, with 
an overproduction of MMP-2 and MMP-9 within the ¢d 
~. aorhc wall integral to the process. Freestone t al. :8 a~ 
suggested that MMP-2 might play a role in aneurysm 
3 genesis, whereas MMP-9 may be more important in 
expansion of larger aneurysms. An aetiological role in 
aneurysm genesis for the elastolytic MMPs has been 
suggested by two contemporary studies which dem- 
2 onstrated that smooth muscle cells cultured from the 
C E A10 A100 abdominal aneurysm wall expressed higher levels of 
*(p < 0.007) **(p < 0.013) MMP-2 than cells from control tissue culture. -'9'3° These 
results suggested that a primary elastoytic insult from 
Fig. 4. Graph plotting the MMP-9 activity (median values and Q3) 
m arbitrary denmtometrlc umts for the cultured control (C) and high levels of MMP-2 may initiate aneurysm formation 
elastase xposed segments (E) and demonstrating that MMP-9 ac- and growth. Theoretically, elastin degradation will 
tlvlty was progressively potentiated by an mcreasmg dose of am- release lastin derived peptides, 31which further stimu- 
lo&pme at 10 and 100 gg/1 (A10 and A100) late  MMP production and a cascade of events leading 
to aneurysm formation. Recent i  vitro investigations 
Discussion from our department have confirmed that an initial 
wave of elastin degradation may induce aneurysmal 
The scale of the rise in incidence of abdominal aortic type changes in arterial tissue, 2° and these sequelae 
aneurysm in contrast o that of peripheral vascular have also been observed in the elastase infusion animal 
disease suggests that it is probably not simply an model or aneurysmal d isease .  32-34 The evidence sug- 
artefact of an ageing population or improved dia- gests that MMPs-2 and -9 are intimately involved in 
gnosis. 3Despite this, similar risk factors are associated aneurysm pathogenesis and growth. The potentiation 
with both pathologies, 25 suggesting that other un- of their action may therefore accelerate aneurysm 
determined influences are important durmg the de- growth. 
velopment of aneurysmal disease. Roth et al. have recently demonstrated that a number 
Animal research as identified agents that accelerate of calcium antagonists, including amlodipine, en- 
aneurysm growth or precipitate rupture. Redly et al. hanced human VSMC MMP- activity and inhibited 
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TIMP-2 transcription i v itro 19 They suggested that this The concentrations of amlodipine used in this study 
ability to modulate ECM metabolism was protective are in keeping with those achieved in elderly patients 
in atherosclerosis. 19 The increase in MMP-2 activity taking a standard oral dose for hypertension. 45 Further 
occurred in the presence of lower mtracellular calcium studies are required to establish whether the detri- 
levels, a finding that was consistent with the work of mental effect of calcium antagonists on elastin de- 
Lohi and Keski-Oja, who showed that the pericellular struction and enhanced MMP activity described in this 
gelatinolytic activity of MMP-2 and MMP-9 was in- study are observed in an animal model or man. 
hiblted by increasing intracellular calcium levels with 
calcium ionophores. 3sThe results of this study are in 
keeping with both these previous investigations. We 
have shown that the calcium antagonist, amlodipine, Acknowledgements  
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